SRRA insider filings

Sierra Oncology, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2022-07-01. Screen SRRA transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for SRRA between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Sierra Oncology, Inc.

FiledFormInsiderReported transactionsSource
2022-07-014Sinclair Andrew — DirectorDisposition to issuer (D): 1,314,127 @ $55 · Disposition to issuer (D): 1,500 (derivative) · Disposition to issuer (D): 6,874 (derivative) · Disposition to issuer (D): 6,000 (derivative) · Disposition to issuer (D): 871,125 (derivative) @ $45.98EDGAR
2022-07-014Vivo Opportunity, LLC — Director, 10% owner
Vivo Opportunity Fund Holdings, L.P. — Director, 10% owner
Vivo Capital IX, LLC — Director, 10% owner
Vivo Capital Fund IX, L.P. — Director, 10% owner
VIVO VENTURES VII, LLC — Director, 10% owner
Vivo Ventures Fund VII, L.P. — Director, 10% owner
Vivo Ventures VII Affiliates Fund, L.P. — Director, 10% owner
Disposition to issuer (D): 161,712 @ $55 · Disposition to issuer (D): 2,735,853 @ $55 · Disposition to issuer (D): 431,947 @ $55 · Disposition to issuer (D): 324,740 (derivative) @ $0 · Disposition to issuer (D): 1,455,384 (derivative) @ $0 · Disposition to issuer (D): 75,749 (derivative) @ $0EDGAR
2022-07-014Ashiya Mona — Director, 10% ownerDisposition to issuer (D): 1,511,362 @ $55 · Disposition to issuer (D): 226,704 @ $55 · Disposition to issuer (D): 226,704 @ $55 · Disposition to issuer (D): 1,500 (derivative) @ $0 · Disposition to issuer (D): 6,874 (derivative) @ $0 · Disposition to issuer (D): 6,000 (derivative) @ $0 · +3 moreEDGAR
2022-07-014Aggarwal Gaurav — DirectorDisposition to issuer (D): 2,735,853 @ $55 · Disposition to issuer (D): 1,500 (derivative) @ $0 · Disposition to issuer (D): 6,874 (derivative) @ $0 · Disposition to issuer (D): 6,000 (derivative) @ $0 · Disposition to issuer (D): 1,455,384 (derivative) @ $0EDGAR
2022-07-014Klencke Barbara — Chief Medical OfficerDisposition to issuer (D): 10,000 @ $55 · Disposition to issuer (D): 5,000 @ $55 · Disposition to issuer (D): 11,744 (derivative) @ $0 · Disposition to issuer (D): 2,061 (derivative) @ $0 · Disposition to issuer (D): 11,399 (derivative) @ $0 · Disposition to issuer (D): 1,749 (derivative) @ $0 · +6 moreEDGAR
2022-07-014Jagpal Sukhi — Chief Financial OfficerDisposition to issuer (D): 3,859 (derivative) @ $0 · Disposition to issuer (D): 1,218 (derivative) @ $0 · Disposition to issuer (D): 4,200 (derivative) @ $0 · Disposition to issuer (D): 1,750 (derivative) @ $0 · Disposition to issuer (D): 4,509 (derivative) @ $0 · Disposition to issuer (D): 5,000 (derivative) @ $0 · +5 moreEDGAR
2022-07-014Pelzer Robert — DirectorDisposition to issuer (D): 671 (derivative) @ $0 · Disposition to issuer (D): 970 (derivative) @ $0 · Disposition to issuer (D): 625 (derivative) @ $0 · Disposition to issuer (D): 625 (derivative) @ $0 · Disposition to issuer (D): 750 (derivative) @ $0 · Disposition to issuer (D): 16,686 (derivative) @ $0 · +1 moreEDGAR
2022-07-014Cooper Jeffrey H — DirectorDisposition to issuer (D): 1,941 (derivative) @ $0 · Disposition to issuer (D): 625 (derivative) @ $0 · Disposition to issuer (D): 625 (derivative) @ $0 · Disposition to issuer (D): 750 (derivative) @ $0 · Disposition to issuer (D): 18,061 (derivative) @ $0 · Disposition to issuer (D): 6,000 (derivative) @ $0EDGAR
2022-07-014Allen Andrew R — Director, 10% ownerDisposition to issuer (D): 1,650 @ $55 · Disposition to issuer (D): 750 (derivative) @ $0 · Disposition to issuer (D): 1,250 (derivative) @ $0 · Disposition to issuer (D): 625 (derivative) @ $0 · Disposition to issuer (D): 12,030 (derivative) @ $0 · Disposition to issuer (D): 6,000 (derivative) @ $0EDGAR
2022-07-014Collard Craig A — DirectorDisposition to issuer (D): 13,500 @ $55 · Disposition to issuer (D): 10,000 (derivative) @ $0 · Disposition to issuer (D): 6,000 (derivative) @ $0EDGAR
2022-07-014DILLY STEPHEN GEORGE — CEO and President, DirectorDisposition to issuer (D): 5,000 @ $55 · Disposition to issuer (D): 520,000 (derivative) @ $0 · Disposition to issuer (D): 260,000 (derivative) @ $0 · Disposition to issuer (D): 92,000 (derivative) @ $0 · Disposition to issuer (D): 165,000 (derivative) @ $0EDGAR
2022-07-014Thomson Mary Christina — General CounselDisposition to issuer (D): 92,000 (derivative) @ $0 · Disposition to issuer (D): 49,000 (derivative) @ $0 · Disposition to issuer (D): 12,900 (derivative) @ $0 · Disposition to issuer (D): 35,000 (derivative) @ $0EDGAR
2022-07-014Turner William D. — Chief Reg & Tech Ops OfficerDisposition to issuer (D): 75,000 (derivative) @ $0 · Disposition to issuer (D): 49,000 (derivative) @ $0 · Disposition to issuer (D): 12,300 (derivative) @ $0 · Disposition to issuer (D): 35,000 (derivative) @ $0EDGAR
2022-07-014Norrett Kevin — Chief Business OfficerDisposition to issuer (D): 100,000 (derivative) @ $0 · Disposition to issuer (D): 49,000 (derivative) @ $0 · Disposition to issuer (D): 11,700 (derivative) @ $0 · Disposition to issuer (D): 35,000 (derivative) @ $0EDGAR
2022-07-014Oliger Christy J. — DirectorDisposition to issuer (D): 18,000 (derivative) @ $0EDGAR
2022-07-014Erbez Georgia — DirectorDisposition to issuer (D): 18,000 (derivative) @ $0EDGAR
2022-07-014ORBIMED ADVISORS LLC — Director, 10% owner
ORBIMED CAPITAL LLC — Director, 10% owner
OrbiMed Genesis GP LLC — Director, 10% owner
OrbiMed Capital GP VII LLC — Director, 10% owner
Disposition to issuer (D): 1,511,362 @ $55 · Disposition to issuer (D): 226,704 @ $55 · Disposition to issuer (D): 226,704 @ $55 · Disposition to issuer (D): 1,136,250 (derivative) @ $0 · Disposition to issuer (D): 170,437 (derivative) @ $0 · Disposition to issuer (D): 170,437 (derivative) @ $0EDGAR
2022-06-174Turner William D. — Chief Reg & Tech Ops OfficerGrant/award (A): 12,250 (derivative) @ $0EDGAR
2022-06-174Norrett Kevin — Chief Business OfficerGrant/award (A): 12,250 (derivative) @ $0EDGAR
2022-06-174Klencke Barbara — Chief Medical OfficerGrant/award (A): 12,250 (derivative) @ $0EDGAR
2022-06-174Jagpal Sukhi — Chief Financial OfficerGrant/award (A): 12,250 (derivative) @ $0EDGAR
2022-06-174DILLY STEPHEN GEORGE — CEO and President, DirectorGrant/award (A): 65,000 (derivative) @ $0EDGAR
2022-06-174Thomson Mary Christina — General Counsel, CCO & Sec'yGrant/award (A): 12,250 (derivative) @ $0EDGAR
2022-04-294Longitude Capital Partners III, LLC — 10% owner
Longitude Venture Partners III, L.P. — 10% owner
Tammenoms Bakker Juliet — 10% owner
ENRIGHT PATRICK G — 10% owner
Longitude Prime Partners, LLC — 10% owner
Longitude Prime Fund, L.P. — 10% owner
Other (J): 175,000 @ $0 · Other (J): 1,964,771 @ $0 · Other (J): 5,023 @ $0 · Other (J): 2,152 @ $0 · Other (J): 7,175 @ $0 · Other (J): 588 @ $0 · +2 moreEDGAR
2022-04-074Turner William D. — Chief Reg & Tech Ops OfficerOption exercise (M): 100 @ $12.05 · Sale (S): 100 @ $37.09 · Option exercise (M): 6,347 @ $12.05 · Sale (S): 6,347 @ $37.25 · Option exercise (M): 100 (derivative) @ $0 · Option exercise (M): 6,347 (derivative) @ $0EDGAR
2022-04-044Thomson Mary Christina — General Counsel, CCO & Sec'yOption exercise (M): 2,000 @ $13.04 · Sale (S): 2,000 @ $35.14 · Option exercise (M): 2,000 (derivative) @ $0EDGAR
2022-03-224Turner William D. — Chief Reg & Tech Ops OfficerOption exercise (M): 100 @ $12.05 · Sale (S): 100 @ $37.05 · Option exercise (M): 100 (derivative) @ $0EDGAR
2022-03-174Turner William D. — Chief Reg & Tech Ops OfficerOption exercise (M): 3,453 @ $12.05 · Sale (S): 3,453 @ $37.06 · Option exercise (M): 3,453 (derivative) @ $0EDGAR
2022-03-144DILLY STEPHEN GEORGE — CEO and President, DirectorGrant/award (A): 165,000 (derivative) @ $0EDGAR
2022-03-144Jagpal Sukhi — Chief Financial OfficerGrant/award (A): 50,000 (derivative) @ $0EDGAR
2022-03-144Klencke Barbara — Chief Medical OfficerGrant/award (A): 50,000 (derivative) @ $0EDGAR
2022-03-144Norrett Kevin — Chief Business OfficerGrant/award (A): 35,000 (derivative) @ $0EDGAR
2022-03-144Turner William D. — Chief Reg & Tech Ops OfficerGrant/award (A): 35,000 (derivative) @ $0EDGAR
2022-03-144Thomson Mary Christina — General Counsel, CCO & Sec'yGrant/award (A): 35,000 (derivative) @ $0EDGAR
2022-03-044Thomson Mary Christina — General Counsel, CCO & Sec'yOption exercise (M): 2,000 @ $13.04 · Sale (S): 2,000 @ $30.60 · Option exercise (M): 2,000 (derivative) @ $0EDGAR
2022-02-084Turner William D. — Chief Reg & Tech Ops OfficerOption exercise (M): 10,000 @ $12.05 · Sale (S): 10,000 @ $32.32 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2022-02-044Thomson Mary Christina — General Counsel, CCO & Sec'yOption exercise (M): 2,000 @ $13.04 · Sale (S): 2,000 @ $29.78 · Option exercise (M): 2,000 (derivative) @ $0EDGAR
2022-02-024Richardson Joshua — Director, 10% ownerPurchase (P): 175,000 @ $27EDGAR
2022-02-024Longitude Capital Partners III, LLC — 10% owner
Longitude Venture Partners III, L.P. — 10% owner
Tammenoms Bakker Juliet — 10% owner
ENRIGHT PATRICK G — 10% owner
Longitude Prime Partners, LLC — 10% owner
Longitude Prime Fund, L.P. — 10% owner
Purchase (P): 175,000 @ $27EDGAR
2022-02-014Sinclair Andrew — DirectorOption exercise/expiry (X): 287,471 @ $13.20 · Purchase (P): 150,000 @ $27 · Option exercise/expiry (X): 287,471 (derivative) @ $0EDGAR
2022-02-014Abingworth LLP — 10% ownerOption exercise/expiry (X): 287,471 @ $13.20 · Purchase (P): 150,000 @ $27 · Option exercise/expiry (X): 287,471 (derivative) @ $0EDGAR
2022-01-314Vivo Opportunity, LLC — 10% owner
Vivo Opportunity Fund, L.P. — 10% owner
Vivo Capital IX, LLC — 10% owner
Vivo Capital Fund IX, L.P. — 10% owner
VIVO VENTURES VII, LLC — 10% owner
Vivo Ventures Fund VII, L.P. — 10% owner
Vivo Ventures VII Affiliates Fund, L.P. — 10% owner
Purchase (P): 800,000 @ $27EDGAR
2022-01-314Aggarwal Gaurav — Director, 10% ownerPurchase (P): 800,000 @ $27EDGAR
2022-01-284Kowalski Mark — Chief, Research & Early DevGrant/award (A): 12,250 (derivative) @ $0EDGAR
2022-01-284Norrett Kevin — Chief Business OfficerGrant/award (A): 12,250 (derivative) @ $0EDGAR
2022-01-284DILLY STEPHEN GEORGE — CEO and President, DirectorGrant/award (A): 65,000 (derivative) @ $0EDGAR
2022-01-284Jagpal Sukhi — Chief Financial OfficerGrant/award (A): 12,250 (derivative) @ $0EDGAR
2022-01-284Thomson Mary Christina — General Counsel & SecretaryOption exercise (M): 2,000 @ $13.04 · Sale (S): 2,000 @ $29 · Option exercise (M): 2,000 (derivative) @ $0 · Grant/award (A): 12,250 (derivative) @ $0EDGAR
2022-01-284Turner William D. — Chief Reg & Tech Ops OfficerOption exercise (M): 5,000 @ $12.05 · Sale (S): 5,000 @ $27.05 · Option exercise (M): 5,000 (derivative) @ $0 · Grant/award (A): 12,250 (derivative) @ $0EDGAR
2022-01-284ORBIMED ADVISORS LLC — Director, 10% owner
OrbiMed Capital GP VII LLC — Director, 10% owner
ORBIMED CAPITAL LLC — Director, 10% owner
OrbiMed Genesis GP LLC — Director, 10% owner
Option exercise/expiry (X): 374,962 @ $13.20 · Option exercise/expiry (X): 56,244 @ $13.20 · Option exercise/expiry (X): 56,244 @ $13.20 · Option exercise/expiry (X): 374,962 (derivative) @ $0 · Option exercise/expiry (X): 56,244 (derivative) @ $0 · Option exercise/expiry (X): 56,244 (derivative) @ $0EDGAR

Recent 8-K events — Sierra Oncology, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2022-07-018-K1.02 — Termination of a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2022-06-298-K5.07 — Submission of Matters to a Vote of Security Holders
8.01 — Other Events
EDGAR
2022-06-228-K8.01 — Other EventsEDGAR
2022-06-018-K8.01 — Other EventsEDGAR
2022-05-068-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2022-04-138-K1.01 — Entry into a Material Definitive Agreement
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2022-03-238-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2022-03-108-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2022-03-078-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2022-01-278-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=SRRA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs